Vitrakvi Continues to Improve Survival, Safety in TRK Fusion GI Cancers
In patients with TRK fusion GI cancers, Vitrakvi continued to show improvements regarding responses to treatment, survival and safety, research found.
Stay updated with breaking news from Gi Cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients with TRK fusion GI cancers, Vitrakvi continued to show improvements regarding responses to treatment, survival and safety, research found.
The European Commission has approved new indications for pembrolizumab in combination with chemotherapy in select patients with gastric or gastroesophageal adenocarcinoma and select patients with biliary tract cancer.
India News: Dr. Prateek Sharma specializes in GI cancers and actively explores cutting-edge technologies such as digital health, artificial intelligence, and adva
Emerging treatments, particularly claudin 18.2, a potential new biomarker in the HER2-negative gastric and gastroesophageal junction cancer space, were highlights of the 2023 ASCO Gastrointestinal Cancers Symposium.
This year bringing their campaign of terror to the shores of alex ortiz, cbs news, cairo. >> glor: we've long been told aspirin can help reduce heart disease. now a new study says long-term regular aspirin use can substantially cut the risk of some kinds of cancer. here now to explain is dr. heather yeo of new york presbyterian-weill cornelle medical center. doctor, good to see you. why was this study so significant? >> thanks, jeff. actually, the study is important because it's one of the first studies to study patients, 130,000 patients actually, for such a long period of time. they studied ...